• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌 30kDa 和 38kDa 抗原诱导人树突状细胞部分成熟,使 CD4(+) T 细胞应答向 IL-4 产生方向偏移。

The 30-kDa and 38-kDa antigens from Mycobacterium tuberculosis induce partial maturation of human dendritic cells shifting CD4(+) T cell responses towards IL-4 production.

机构信息

Institute of Virology and Immunobiology, University of Würzburg, Würzburg, Germany.

出版信息

BMC Immunol. 2013 Oct 3;14:48. doi: 10.1186/1471-2172-14-48.

DOI:10.1186/1471-2172-14-48
PMID:24089996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3852591/
Abstract

BACKGROUND

Mycobacterium tuberculosis (Mtb) infections are still a major cause of death among all infectious diseases. Although 99% of individuals infected with Mtb develop a CD4(+) Th1 and CD8(+) T cell mediated immunity as measured by tuberculin skin test, this results only in partial protection and Mtb vaccines are not effective. Deviation of immune responses by pathogens towards a Th2 profile is a common mechanism of immune evasion, typically leading to the persistence of the microbes.

RESULTS

Here we tested the stimulatory capacity of selective Mtb antigens on human monocyte-derived dendritic cell (DC) maturation and cytokine production. DC maturation markers CD80, CD86 and CD83 were readily upregulated by H37Ra- and H37Rv-associated antigens, the 30-kDa (from Ag85 B complex) and 38-KDa Mtb antigens only partially induced these markers. All Mtb antigens induced variable levels of IL-6 and low levels of IL-10, there was no release of IL-12p70 detectable. Substantial IL-12p40 production was restricted to LPS or H37Ra and H37Rv preparations. Although the proliferation levels of primary T cell responses were comparable using all the differentially stimulated DC, the 30-kDa and 38-kDa antigens showed a bias towards IL-4 secretion of polarized CD4(+) T cells after secondary stimulation as compared to H37Ra and H37Rv preparations.

CONCLUSION

Together our data indicate that 30-kDa and 38-kDa Mtb antigens induced only partial DC maturation shifting immune responses towards a Th2 profile.

摘要

背景

结核分枝杆菌(Mtb)感染仍然是所有传染病中导致死亡的主要原因。尽管 99%的 Mtb 感染者通过结核菌素皮肤试验表现出 CD4(+) Th1 和 CD8(+) T 细胞介导的免疫,但这仅导致部分保护,并且 Mtb 疫苗无效。病原体将免疫反应向 Th2 表型偏离是免疫逃避的常见机制,通常导致微生物的持续存在。

结果

在这里,我们测试了选择性 Mtb 抗原对人单核细胞衍生树突状细胞(DC)成熟和细胞因子产生的刺激能力。DC 成熟标志物 CD80、CD86 和 CD83 很容易被 H37Ra 和 H37Rv 相关抗原上调,而 30-kDa(来自 Ag85 B 复合物)和 38-KDa Mtb 抗原仅部分诱导这些标志物。所有 Mtb 抗原诱导可变水平的 IL-6 和低水平的 IL-10,没有检测到 IL-12p70 的释放。大量的 IL-12p40 产生仅限于 LPS 或 H37Ra 和 H37Rv 制剂。尽管使用所有差异刺激的 DC 均可检测到原代 T 细胞反应的增殖水平相当,但与 H37Ra 和 H37Rv 制剂相比,30-kDa 和 38-kDa Mtb 抗原在二次刺激后显示出向极化 CD4(+) T 细胞分泌 IL-4 的偏向性。

结论

我们的数据表明,30-kDa 和 38-kDa Mtb 抗原仅诱导部分 DC 成熟,将免疫反应向 Th2 表型转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/3852591/f3ac8168875f/1471-2172-14-48-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/3852591/b0a40b562ea1/1471-2172-14-48-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/3852591/6a498693adaf/1471-2172-14-48-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/3852591/5b4233bb1dfd/1471-2172-14-48-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/3852591/f3ac8168875f/1471-2172-14-48-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/3852591/b0a40b562ea1/1471-2172-14-48-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/3852591/6a498693adaf/1471-2172-14-48-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/3852591/5b4233bb1dfd/1471-2172-14-48-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/3852591/f3ac8168875f/1471-2172-14-48-4.jpg

相似文献

1
The 30-kDa and 38-kDa antigens from Mycobacterium tuberculosis induce partial maturation of human dendritic cells shifting CD4(+) T cell responses towards IL-4 production.结核分枝杆菌 30kDa 和 38kDa 抗原诱导人树突状细胞部分成熟,使 CD4(+) T 细胞应答向 IL-4 产生方向偏移。
BMC Immunol. 2013 Oct 3;14:48. doi: 10.1186/1471-2172-14-48.
2
TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells.TLR8 刺激增强了西妥昔单抗介导的自然杀伤细胞对头颈部癌细胞的裂解作用和树突状细胞对 EGFR 特异性 CD8+T 细胞的交叉呈递。
Cancer Immunol Immunother. 2013 Aug;62(8):1347-57. doi: 10.1007/s00262-013-1437-3. Epub 2013 May 18.
3
Effect of oxygen levels on the physiology of dendritic cells: implications for adoptive cell therapy.氧气水平对树突状细胞生理学的影响:对过继细胞疗法的启示。
Mol Med. 2011 Sep-Oct;17(9-10):910-6. doi: 10.2119/molmed.2011.00031. Epub 2011 Jun 1.
4
Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.肾上腺素预刺激的小鼠骨髓来源树突状细胞促进 CD4+T 细胞产生白细胞介素-17A 和白细胞介素-4,但不产生干扰素-γ。
Brain Behav Immun. 2010 Oct;24(7):1126-36. doi: 10.1016/j.bbi.2010.05.003. Epub 2010 May 31.
5
Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer.肿瘤组织微环境可抑制结直肠癌树突状细胞的成熟。
PLoS One. 2011;6(11):e27944. doi: 10.1371/journal.pone.0027944. Epub 2011 Nov 18.
6
Effect of Pru p 3 on dendritic cell maturation and T-lymphocyte proliferation in peach allergic patients.桃过敏患者中普李 3 对树突状细胞成熟和 T 淋巴细胞增殖的影响。
Ann Allergy Asthma Immunol. 2012 Jul;109(1):52-8. doi: 10.1016/j.anai.2012.05.017.
7
Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.托西酸舒托必利对哮喘患者单核细胞来源树突状细胞分化及功能的抑制作用
Clin Exp Allergy. 2007 Jul;37(7):1083-9. doi: 10.1111/j.1365-2222.2006.02616.x.
8
Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4.初始免疫应答中Th2细胞分化的诱导:从经白细胞介素-10处理的贴壁细胞培养物中分离出的树突状细胞启动初始CD4+T细胞分泌白细胞介素-4。
Int Immunol. 1998 Aug;10(8):1017-26. doi: 10.1093/intimm/10.8.1017.
9
Isoflavones, genistein and daidzein, regulate mucosal immune response by suppressing dendritic cell function.异黄酮、染料木黄酮和大豆苷元通过抑制树突状细胞的功能来调节黏膜免疫反应。
PLoS One. 2012;7(10):e47979. doi: 10.1371/journal.pone.0047979. Epub 2012 Oct 22.
10
Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cell.利用人工抗原呈递细胞诱导 HLA-DP4 限制性抗存活素 Th1 和 Th2 反应。
Clin Cancer Res. 2011 Aug 15;17(16):5392-401. doi: 10.1158/1078-0432.CCR-10-3083. Epub 2011 Jun 24.

引用本文的文献

1
Fitness costs of Mycobacterium tuberculosis resistant to rifampicin is compensated by rapid Th2 polarization mediated by early and high IL-4 production during mice infection.在小鼠感染期间,结核分枝杆菌对利福平耐药的适应性代价通过早期和高水平白细胞介素-4产生介导的快速Th2极化得到补偿。
Sci Rep. 2025 Jan 22;15(1):2811. doi: 10.1038/s41598-024-81446-3.
2
Rv2005c Induces Dendritic Cell Maturation and Th1 Responses and Exhibits Immunotherapeutic Activity by Fusion with the Rv2882c Protein.Rv2005c通过与Rv2882c蛋白融合诱导树突状细胞成熟和Th1反应并展现出免疫治疗活性。
Vaccines (Basel). 2020 Jul 10;8(3):370. doi: 10.3390/vaccines8030370.
3

本文引用的文献

1
Divergent effects of mycobacterial cell wall glycolipids on maturation and function of human monocyte-derived dendritic cells.分枝杆菌细胞壁糖脂对人单核细胞来源树突状细胞成熟和功能的影响不同。
PLoS One. 2012;7(8):e42515. doi: 10.1371/journal.pone.0042515. Epub 2012 Aug 3.
2
Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responses.类似 TNF 或布氏锥虫抗原诱导的炎症性 DC 成熟特征指导默认的 Th2 细胞反应。
Eur J Immunol. 2011 Dec;41(12):3479-94. doi: 10.1002/eji.201141631. Epub 2011 Nov 3.
3
Cytokines in response to proteins predicted in genomic regions of difference of Mycobacterium tuberculosis.
Mucosal-Associated Invariant T Cells Develop an Innate-Like Transcriptomic Program in Anti-mycobacterial Responses.
黏膜相关不变 T 细胞在抗分枝杆菌反应中形成固有样转录组程序。
Front Immunol. 2020 Jun 9;11:1136. doi: 10.3389/fimmu.2020.01136. eCollection 2020.
4
Serotype 2 Infection Impairs Interleukin-12 Production and the MHC-II-Restricted Antigen Presentation Capacity of Dendritic Cells.2型血清型感染会损害树突状细胞的白细胞介素-12产生及MHC-II限制性抗原呈递能力。
Front Immunol. 2018 May 30;9:1199. doi: 10.3389/fimmu.2018.01199. eCollection 2018.
5
Cellular immune response in MDR-TB patients to different protein expression of MDR and susceptible Mycobacterium tuberculosis: Rv0147, a novel MDR-TB biomarker.MDR-TB 患者对不同蛋白表达的 MDR 和敏感结核分枝杆菌的细胞免疫反应:Rv0147,一种新的 MDR-TB 生物标志物。
Immunol Res. 2018 Feb;66(1):59-66. doi: 10.1007/s12026-017-8971-6.
6
LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages.巨噬细胞感染结核分枝杆菌期间LL-37的免疫调节活性。
Infect Immun. 2015 Dec;83(12):4495-503. doi: 10.1128/IAI.00936-15. Epub 2015 Sep 8.
针对结核分枝杆菌基因组区域差异预测的蛋白产生的细胞因子。
Microbiol Immunol. 2011 Apr;55(4):267-78. doi: 10.1111/j.1348-0421.2011.00307.x.
4
Future vaccination strategies against tuberculosis: thinking outside the box.未来结核病疫苗接种策略:跳出固有思维。
Immunity. 2010 Oct 29;33(4):567-77. doi: 10.1016/j.immuni.2010.09.015.
5
T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients.结核患者外周血中的调节性 T 细胞和 Th1/Th2 细胞因子。
Eur J Clin Microbiol Infect Dis. 2010 Jun;29(6):643-50. doi: 10.1007/s10096-010-0908-0. Epub 2010 Mar 21.
6
Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors.结核分枝杆菌对抗原呈递的调控: toll 样受体的作用。
Nat Rev Microbiol. 2010 Apr;8(4):296-307. doi: 10.1038/nrmicro2321.
7
Spotlight on Mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge?聚焦分枝杆菌和树突状细胞:新型抗结核靶点是否会出现?
EMBO Mol Med. 2009 Apr;1(1):19-29. doi: 10.1002/emmm.200900008.
8
Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)-vaccinated healthy subjects.糖尿病和非糖尿病结核病患者以及卡介苗(BCG)接种的健康受试者外周血单个核细胞的分枝杆菌抗原诱导的1型辅助性T细胞(Th1)和2型辅助性T细胞(Th2)反应性
Clin Exp Immunol. 2009 Oct;158(1):64-73. doi: 10.1111/j.1365-2249.2009.04000.x.
9
Antimicrobial mechanisms of phagocytes and bacterial evasion strategies.吞噬细胞的抗菌机制及细菌逃避策略。
Nat Rev Microbiol. 2009 May;7(5):355-66. doi: 10.1038/nrmicro2128.
10
Cell-mediated immune responses in tuberculosis.结核病中的细胞介导免疫反应。
Annu Rev Immunol. 2009;27:393-422. doi: 10.1146/annurev.immunol.021908.132703.